RDY Cash And Equivalents from 2010 to 2024

RDY Stock  USD 13.99  0.31  2.17%   
Dr Reddys Cash And Equivalents yearly trend continues to be fairly stable with very little volatility. Cash And Equivalents is likely to outpace its year average in 2024. During the period from 2010 to 2024, Dr Reddys Cash And Equivalents regression line of annual values had r-squared of  0.08 and arithmetic mean of  1,856,344,000. View All Fundamentals
 
Cash And Equivalents  
First Reported
2010-12-31
Previous Quarter
2.6 B
Current Value
2.8 B
Quarterly Volatility
1.1 B
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Dr Reddys financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dr Reddys' main balance sheet or income statement drivers, such as Interest Expense of 1.8 B, Total Revenue of 293.1 B or Gross Profit of 171.8 B, as well as many indicators such as Price To Sales Ratio of 0.7, Dividend Yield of 0.0274 or PTB Ratio of 0.84. RDY financial statements analysis is a perfect complement when working with Dr Reddys Valuation or Volatility modules.
  
Check out the analysis of Dr Reddys Correlation against competitors.

Latest Dr Reddys' Cash And Equivalents Growth Pattern

Below is the plot of the Cash And Equivalents of Dr Reddys Laboratories over the last few years. It is Dr Reddys' Cash And Equivalents historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Dr Reddys' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 2.93 B10 Years Trend
Pretty Stable
   Cash And Equivalents   
       Timeline  

RDY Cash And Equivalents Regression Statistics

Arithmetic Mean1,856,344,000
Geometric Mean1,109,583,282
Coefficient Of Variation61.64
Mean Deviation1,020,229,333
Median2,555,000,000
Standard Deviation1,144,281,933
Sample Variance1309381.1T
Range2.9B
R-Value(0.28)
Mean Square Error1298833.9T
R-Squared0.08
Significance0.31
Slope(71,875,286)
Total Sum of Squares18331336T

RDY Cash And Equivalents History

20242.8 B
20232.6 B
20222.9 B
202175 M
2020316 M
2019118 M
2018111 M

About Dr Reddys Financial Statements

Dr Reddys investors use historical fundamental indicators, such as Dr Reddys' Cash And Equivalents, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Dr Reddys. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cash And Equivalents2.6 B2.8 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for RDY Stock Analysis

When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.